Literature DB >> 9377594

Free radicals and antioxidants in chemotherapy-induced toxicity.

N I Weijl1, F J Cleton, S Osanto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9377594     DOI: 10.1016/s0305-7372(97)90012-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  42 in total

1.  Disturbance of purine nucleotide metabolism: a possible early key event in development of intestinal damage induced by chemotherapy.

Authors:  J E Johansson; B Soussi; U Bagge; T Ekman
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

Review 2.  The Role of Biomarkers of Oxidative Stress in Breast Cancer Risk and Prognosis: A Systematic Review of the Epidemiologic Literature.

Authors:  Jasmine D Lee; Qiuyin Cai; Xiao Ou Shu; Sarah J Nechuta
Journal:  J Womens Health (Larchmt)       Date:  2017-02-02       Impact factor: 2.681

3.  Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats.

Authors:  Ahmet Koc; Mehmet Duru; Harun Ciralik; Ramazan Akcan; Sadik Sogut
Journal:  Mol Cell Biochem       Date:  2005-10       Impact factor: 3.396

4.  Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP.

Authors:  Beata Kosmider; Izabela Wojcik; Regina Osiecka; Jacek Bartkowiak; Elzbieta Zyner; Justyn Ochocki; Pawel Liberski
Journal:  Invest New Drugs       Date:  2005-08       Impact factor: 3.850

5.  An unsupervised MVA method to compare specific regions in human breast tumor tissue samples using ToF-SIMS.

Authors:  Blake M Bluestein; Fionnuala Morrish; Daniel J Graham; Jamie Guenthoer; David Hockenbery; Peggy L Porter; Lara J Gamble
Journal:  Analyst       Date:  2016-03-21       Impact factor: 4.616

Review 6.  Antioxidants in health and disease.

Authors:  I S Young; J V Woodside
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

7.  Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo.

Authors:  Qiang Tan; Jing Li; Han-wei Yin; Li-hui Wang; Wan-chen Tang; Fang Zhao; Xin-min Liu; Hui-hui Zeng
Journal:  Invest New Drugs       Date:  2009-03-07       Impact factor: 3.850

Review 8.  Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.

Authors:  L R Wiseman; C M Spencer
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

9.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Authors:  Mary Ann Richardson; Louise C Mâsse; Kelly Nanny; Christina Sanders
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

10.  Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.

Authors:  Katja Ott; Florian Lordick; Karen Becker; Kurt Ulm; JörgRüdiger Siewert; Heinz Höfler; Gisela Keller
Journal:  Int J Colorectal Dis       Date:  2008-04-29       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.